Stay updated on SubQ Efgartigimod in CIDP Clinical Trial
Sign up to get notified when there's something new on the SubQ Efgartigimod in CIDP Clinical Trial page.

Latest updates to the SubQ Efgartigimod in CIDP Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of the study details, indicating access to the record is blocked or unavailable.SummaryDifference16%

- Check17 days agoChange DetectedThe page's revision label was updated to v3.7.0, indicating a newer version of the page metadata.SummaryDifference0.0%

- Check38 days agoChange DetectedA funding attribution for the NIH grant/contract was added to the study record, and the page revision was updated to v3.6.6 (replacing v3.6.5).SummaryDifference0.0%

- Check45 days agoChange DetectedThe site-wide outage warning and the note about intermittent delays from NCBI services were removed, reducing on-page notices and leaving the study details intact.SummaryDifference0.0%

- Check52 days agoChange DetectedAn outage warning banner was added to the page, informing users that some NCBI services are experiencing intermittent delays and thanking them for their patience while the service is restored.SummaryDifference0.0%

- Check74 days agoChange DetectedA new revision label was added: Revision: v3.6.4, replacing Revision: v3.6.3. This indicates a minor version update to the page's documentation.SummaryDifference0.0%

Stay in the know with updates to SubQ Efgartigimod in CIDP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SubQ Efgartigimod in CIDP Clinical Trial page.